Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSysgroup Regulatory News (SYS)

Share Price Information for Sysgroup (SYS)

Share Price is delayed by 15 minutes
Get Live Data
21.00    2.00 (10.00%)
Bid:
20.00
Ask:
22.00
Spread: 2.00 (10.00%)
Market Cap: £18.42m
SYS Live PriceLast checked at - London Stock Exchange

Intraday Sysgroup Share Chart

Holding(s) in Company

15 Apr 2011 12:05

RNS Number : 0146F
System C Healthcare plc
15 April 2011
 



TR-1: Notification of major interest in shares

1. Identity of the issuer or the underlying issuerof existing shares to which voting rights areattached:

SYSTEM C HEALTHCARE PLC

2 Reason for the notification (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights

X

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

An event changing the breakdown of voting rights

Other (please specify):

3. Full name of person(s) subject to thenotification obligation:

CREDIT SUISSE GROUP AG

4. Full name of shareholder(s)  (if different from 3.):

 

CREDIT SUISSE SECURITIES (EUROPE) LTD

 

5. Date of the transaction and date onwhich the threshold is crossed orreached:

12/04/2011

6. Date on which issuer notified:

14/04/2011

7. Threshold(s) that is/are crossed orreached:

6%

 

8. Notified details:

A: Voting rights attached to shares

Class/type ofshares

if possible usingthe ISIN CODE

Situation previousto the triggeringtransaction

Resulting situation after the triggering transaction

NumberofShares

NumberofVotingRights

Numberof shares

Number of votingrights

% of voting rights

Direct

Direct

Indirect

Direct

Indirect

ORD

GB00B0940H91

 

6,650,000

 

6,650,000

 

N/A

 

N/A

 

7,050,000

 

N/A

 

6.0570%

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financialinstrument

Expirationdate

Exercise/Conversion Period

Number of votingrights that may beacquired if theinstrument isexercised/ converted.

% of votingrights

N/A

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi

Resulting situation after the triggering transaction

Type of financialinstrument

Exercise price

Expiration date

Exercise/Conversion period

Number of voting rights instrument refers to

 

% of voting rights

N/A

Nominal

Delta

Total (A+B+C)

Number of voting rights

Percentage of voting rights

 

7,050,000

 

6.0570%

 

9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable:

 

1. Credit Suisse Group AG

2. Credit Suisse AG

2.1. Credit Suisse Securities (Europe) Ltd

Proxy Voting:

10. Name of the proxy holder:

11. Number of voting rights proxy holder will ceaseto hold:

12. Date on which proxy holder will cease to holdvoting rights:

13. Additional information:

14. Contact name:

Anthony Allen/ Liane Agostini

15. Contact telephone number:

+44 (0) 20 7888 5416/ 3599

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLIAMBTMBMBBJB
Date   Source Headline
8th Jul 20267:00 amRNSFinal Results for the year ended 31 March 2026
2nd Jul 20267:00 amRNSNotice of Results
19th Jun 20261:51 pmRNSHolding(s) in Company
19th May 20267:00 amRNSChange of Registered Office
13th Apr 20267:00 amRNSYear End Trading Update
13th Mar 202610:11 amRNSTransfer of Shares to AI Board Adviser and TVR
13th Mar 202610:11 amRNSTransfer of Shares to AI Board Adviser and TVR
9th Feb 202610:15 amRNS-RIT Infrastructure Refresh Contract Win
3rd Feb 20264:13 pmRNSDirector/PDMR Dealing
29th Jan 20262:11 pmRNS-RContract win with the Scouts Association
22nd Jan 20269:34 amRNSHolding(s) in Company
22nd Dec 20252:08 pmRNSAcquisition of Saxis Group Limited
22nd Dec 20252:08 pmRNSAcquisition of Saxis Group Limited
9th Dec 202512:06 pmRNS-RAppointment of AI Adviser
3rd Dec 20257:00 amRNSHalf Year Results to 30 September 2025
25th Nov 20257:00 amRNSNotice of Results
16th Sep 20253:38 pmRNSResult of AGM
12th Sep 202510:51 amRNSDirector Dealing
8th Sep 202512:17 pmRNSExercise of Options and Total Voting Rights
3rd Sep 20257:00 amRNSGrant of Options and PDMR Dealings
8th Aug 20257:00 amRNSNotice of AGM and Publication of Accounts
29th Jul 202510:17 amRNSDirector/PDMR Dealing
24th Jul 20257:00 amRNSFinal Results for the year ended 31 March 2025
14th Jul 20257:00 amRNSNotice of Results
29th Apr 20257:00 amRNSYear End Trading Update
20th Mar 202511:34 amRNS-RSysGroup Joins Rubrik's Advanced Partner Program
29th Jan 20259:17 amRNSHolding(s) in Company
28th Jan 20257:00 amRNSDirector/PDMR Dealing
22nd Jan 20257:00 amRNSHolding(s) in Company
19th Dec 202412:45 pmRNSExercise of Options and Total Voting Rights
4th Dec 20244:00 pmRNSPresentation via Investor Meet Company
3rd Dec 20241:00 pmRNSDirector/PDMR Dealing
3rd Dec 20247:00 amRNSHalf Year Results to 30 September 2024
19th Nov 20247:00 amRNSAcquisition & Notice of Results
20th Sep 202411:00 amRNSResult of AGM
12th Sep 20247:00 amRNSAIM Rule 17 and Schedule 2(g) Disclosure
3rd Sep 20247:00 amRNSGrant of Options and Director/PDMR Dealings
21st Aug 20244:50 pmRNSGrant of Options and Director/PDMR Dealings
15th Aug 20247:00 amRNSNotice of AGM and Publication of Annual Report
31st Jul 20247:00 amRNSFinal Results for the year ended 31 March 2024
24th Jul 20247:00 amRNSNotice of Results
28th Jun 202410:10 amRNSHolding(s) in Company
28th Jun 20247:00 amRNSHolding(s) in Company
24th Jun 20244:12 pmRNSResult of General Meeting and Total Voting Rights
14th Jun 20247:00 amRNSResult of Retail Offer
7th Jun 20248:00 amRNSLaunch of Retail Offer
7th Jun 20247:00 amRNSResult of Oversubscribed Placing and Subscription
6th Jun 20245:11 pmRNSProposed Fundraising
3rd Jun 20247:00 amRNSBoard Changes
29th May 20247:00 amRNSStrategic Partnership

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.